Literature DB >> 31405777

Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients.

Sunil D Shenvi1, David J Taber2, Andrew D Hardie3, Jonathan O Botstein3, John W McGillicuddy2.   

Abstract

BACKGROUND: Measures of skeletal muscle abnormalities are rapidly emerging as independent predictors of outcomes after liver transplantation (LT). We describe a simple, novel assessment of myosteatosis acquired prior to liver transplantation using Magnetic Resonance Imaging (MRI) derived fat fraction.
METHODS: A retrospective longitudinal cohort study included clinical and biochemical data from patients who underwent liver transplantation at our institution between Feb 2008 and Aug 2014. Patients transplanted for a diagnosis of hepatocellular carcinoma were excluded from the study. The fat fraction of erector spinae muscles was estimated using MRI at the level where muscle volume was highest, with myosteatosis defined at a cut-off value of 0.8.
RESULTS: 180 patients were included. At baseline, those with myosteatosis were, on average, older, more likely to be female, and more likely to receive a multi-organ transplant (p < 0.05). Patients with pre-transplant myosteatosis, as delineated by MRI derived fat fraction, also had increased length of hospital stay.
CONCLUSION: This preliminary study suggests myosteatosis, as measured by fat fraction on MRI prior to LT, may be associated with increased graft loss and mortality after transplant.
Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31405777     DOI: 10.1016/j.hpb.2019.06.006

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  3 in total

Review 1.  Novel approaches to metabolic assessment and structured exercise to promote recovery in ICU survivors.

Authors:  Jeroen Molinger; Amy M Pastva; John Whittle; Paul E Wischmeyer
Journal:  Curr Opin Crit Care       Date:  2020-08       Impact factor: 3.687

Review 2.  Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions.

Authors:  Maryam Ebadi; Cynthia Tsien; Rahima A Bhanji; Abha R Dunichand-Hoedl; Elora Rider; Maryam Motamedrad; Vera C Mazurak; Vickie Baracos; Aldo J Montano-Loza
Journal:  Cells       Date:  2022-04-04       Impact factor: 6.600

3.  Association of myosteatosis with various body composition abnormalities and longer length of hospitalization in patients with decompensated cirrhosis.

Authors:  Xiaoyu Wang; Mingyu Sun; Yifan Li; Gaoyue Guo; Wanting Yang; Lihong Mao; Zihan Yu; Yangyang Hui; Xiaofei Fan; Binxin Cui; Kui Jiang; Chao Sun
Journal:  Front Nutr       Date:  2022-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.